|
The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare and Medicaid beneficiaries and to users of TrumpRx.gov, the administration's new direct-to-consumer website.
|
RELATED ARTICLES | | |
|
The president's agreement with drug companies involves a range of prices, depending on dose, product and how you're paying.
|
|
